The National People’s Congress (the NPC) conducted its first-round review of the draft PRC Film Industry Promotion Law (《中華人民共和國電影產業促進法(草案)》) (the Draft FIPL) on 30 October 2015.
For the first time, a specific legal framework is in place for foreign investors to invest in medical institutions in China through a wholly foreign-owned enterprise (WFOE).
In January 2013, the National Development and Reform Commission (NDRC) of the People’s Republic of China (PRC) fined six foreign flat-screen manufactures for price-fixing.